youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
MDLN:NASDAQ
Medline Inc
$32.12
arrow_upward
+0.37%(+0.12) 1D
$32.21
arrow_upward
+0.28% (+0.090)bedtimeAfter hours
Closed: Oct 30, 3:00:00 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MDLN...
Open
$31.93
High
$32.32
Low
$31.37
Mkt. cap
42.23B
Avg. vol.
9.32M
Volume
14.57M
P/E ratio
37.99
52-wk high
$50.88
52-wk low
$31.37
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
Open
$31.93
High
$32.32
Low
$31.37
Mkt. cap
42.23B
Avg. vol.
9.32M
Volume
14.57M
P/E ratio
37.99
52-wk high
$50.88
52-wk low
$31.37
EPS
$0.85
Shares outstanding
877.35M
No. of employees
45K
News stories
From web sources and news partners
Benzinga
·
12 hours ago
Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week
About Medline Inc
Analyst ratings
Based on 20 analysts giving stock ratings to MDLN in the past 3 months
Strong buy
Buy
18
Hold
2
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for MDLN in the last 3 months.
Highest
Current $32.12
$55.00 (+71.23%)
Average
$44.59 (+38.82%)
Lowest
$34.00 (+5.85%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Steven Valiquette Mizuho Securities | Buy | Maintained | $45.00 | +40.1% | 10/22/2026 |
Glen Santangelo Barclays | Buy | Maintained | $43.00 | +33.9% | 10/09/2026 |
Michael Cherny Leerink Partners | Buy | Maintained | $43.00 | +33.9% | 10/07/2026 |
Ryan Halsted RBC Capital | Buy | Maintained | $46.00 | +43.2% | 10/06/2026 |
Kevin Caliendo UBS | Buy | Reiterated | $43.00 | +33.9% | 09/25/2026 |
Brandon Vazquez William Blair | Buy | Maintained | - | - | 09/23/2026 |
Jailendra Singh Truist Financial | Buy | Maintained | - | - | 09/22/2026 |
David Larsen BTIG | Buy | Maintained | $55.00 | +71.2% | 08/27/2026 |
Ivan Feinseth Tigress Financial | Buy | Reiterated | $55.00 | +71.2% | 08/14/2026 |
Lisa Gill J.P. Morgan | Buy | Maintained | $46.00 | +43.2% | 08/12/2026 |
Stephen Baxter Wells Fargo | Hold | Reiterated | $34.00 | +5.9% | 08/11/2026 |
Charles Rhyee TD Cowen | Buy | Reiterated | $45.00 | +40.1% | 08/10/2026 |
Andrew Obin Bank of America Securities | Buy | Maintained | - | - | 08/06/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $42.00 | +30.8% | 08/06/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $39.00 | +21.4% | 08/06/2026 |
Rick Wise Stifel Nicolaus | Buy | Reiterated | $45.00 | +40.1% | 08/06/2026 |
Sean Dodge BMO Capital | Buy | Reiterated | $47.00 | +46.3% | 08/05/2026 |
Erin Wright Morgan Stanley | Buy | Maintained | $48.00 | +49.4% | 08/06/2026 |
Pito Chickering Deutsche Bank | Hold | Reiterated | $37.00 | +15.2% | 08/06/2026 |
Daniel Grosslight Citi | Buy | Maintained | $45.00 | +40.1% | 08/05/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $45.00 | +40.1% | 08/05/2026 |
Lee Hambright Bernstein | Buy | Reiterated | $54.00 | +68.1% | 05/07/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $53.00 | +65% | 05/07/2026 |
David Roman Goldman Sachs | Buy | Maintained | $50.00 | +55.7% | 05/06/2026 |
Jason Bednar Piper Sandler | Buy | Maintained | $55.00 | +71.2% | 05/04/2026 |
Patrick Wood Morgan Stanley | Buy | Maintained | $48.00 | +49.4% | 02/25/2026 |
Next call in 3 days
Wed, Nov 4, 4:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.35
Revenue / Est. (USD)
- / 7.72B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 7.12B | 7.79B | 7.35B | 7.68B |
Cost of goods sold | 5.24B | 5.87B | 5.51B | 5.80B |
Cost of revenue | 5.24B | 5.87B | 5.51B | 5.80B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.12B | 1.26B | 1.23B | 1.30B |
Operating expense | 1.30B | 1.47B | 1.42B | 1.82B |
Total operating expenses | 6.54B | 7.34B | 6.93B | 7.62B |
Operating income | 574.00M | 443.00M | 422.00M | 63.00M |
Other non operating income | - | -6.00M | 1.00M | -42.00M |
EBT including unusual items | 345.00M | 206.00M | 291.00M | 235.00M |
EBT excluding unusual items | 351.00M | 276.00M | 291.00M | -97.00M |
Income tax expense | 23.00M | 26.00M | 52.00M | 96.00M |
Effective tax rate | 6.67% | 12.62% | 17.87% | 40.85% |
Other operating expenses | 8.00M | 30.00M | 15.00M | 348.00M |
Net income | 322.00M | 182.00M | 129.00M | 60.00M |
Net profit margin | 4.53% | 2.34% | 1.75% | 0.78% |
Earnings per share | - | 0.31 | 0.33 | 0.50 |
Interest and investment income | 35.00M | 34.00M | 29.00M | 49.00M |
Interest expense | -248.00M | -200.00M | -165.00M | -168.00M |
Net interest expenses | -213.00M | -166.00M | -136.00M | -119.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 827.00M | 704.00M | 676.00M | 319.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events